Design of Early Validation Trials of Biomarkers

by Daniel Normolle, Mack T. Ruffin, Dean Brenner
Published 2005-01-01

Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.

by Lindsay R Dresang, Anna Guastafierro, Reety Arora, Daniel Normolle, Yuan Chang, Patrick S Moore
Published 2013-01-01

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

by Greg M Delgoffe, Kristin DePeaux, Angen Liu, Dan P Zandberg, Ashley V Menk, Maria Velez, Daniel Normolle
Published 2021-05-01

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio

by Aron Popovtzer, Daniel Normolle, Francis P. Worden, Mark E. Prince, Douglas B. Chepeha, Gregory T. Wolf, Carol R. Bradford, Theodore S. Lawrence, Avraham Eisbruch
Published 2014-08-01

Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.

by Muhamuda Kader, Amanda P Smith, Cristiana Guiducci, Elizabeth R Wonderlich, Daniel Normolle, Simon C Watkins, Franck J Barrat, Simon M Barratt-Boyes
Published 2013-01-01